Insider Transactions in Q1 2025 at Laboratory Corp Of America Holdings (LH)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 18
2025
|
Peter J Wilkinson SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,413
-41.49%
|
$347,598
$246.1 P/Share
|
|
Feb 18
2025
|
Peter J Wilkinson SVP, Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,413
+29.32%
|
$230,319
$163.63 P/Share
|
|
Feb 11
2025
|
Peter J Wilkinson SVP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
41
-1.72%
|
$10,045
$245.14 P/Share
|
|
Feb 11
2025
|
Peter J Wilkinson SVP, Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
123
+4.9%
|
-
|
|
Feb 11
2025
|
Amy B. Summy EVP, Chief Marketing Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
55
-1.14%
|
$13,475
$245.14 P/Share
|
|
Feb 11
2025
|
Amy B. Summy EVP, Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
201
+4.0%
|
-
|
|
Feb 11
2025
|
Adam H Schechter President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,226
-1.37%
|
$300,370
$245.14 P/Share
|
|
Feb 11
2025
|
Adam H Schechter President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,963
+3.21%
|
-
|
|
Feb 11
2025
|
Adam H Schechter President & CEO |
SELL
Open market or private sale
|
Direct |
6,121
-6.61%
|
$1,493,524
$244.62 P/Share
|
|
Feb 11
2025
|
Lance Berberian EVP, Special Advisor, Strategy |
SELL
Payment of exercise price or tax liability
|
Direct |
86
-0.51%
|
$21,070
$245.14 P/Share
|
|
Feb 11
2025
|
Lance Berberian EVP, Special Advisor, Strategy |
BUY
Exercise of conversion of derivative security
|
Direct |
323
+1.89%
|
-
|
|
Feb 11
2025
|
Glenn A Eisenberg Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
213
-0.64%
|
$52,185
$245.14 P/Share
|
|
Feb 11
2025
|
Glenn A Eisenberg Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
807
+2.36%
|
-
|
|
Feb 11
2025
|
Mark S Schroeder EVP, Pres Diagnostics & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
134
-2.05%
|
$32,830
$245.14 P/Share
|
|
Feb 11
2025
|
Mark S Schroeder EVP, Pres Diagnostics & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
473
+6.75%
|
-
|
|
Feb 11
2025
|
Vaart Sandra D Van Der EVP, Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
86
-2.41%
|
$21,070
$245.14 P/Share
|
|
Feb 11
2025
|
Vaart Sandra D Van Der EVP, Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
323
+8.3%
|
-
|
|
Feb 11
2025
|
Brian J Caveney EVP, Pres of ED, CMO & CSO |
SELL
Payment of exercise price or tax liability
|
Direct |
136
-0.46%
|
$33,320
$245.14 P/Share
|
|
Feb 11
2025
|
Brian J Caveney EVP, Pres of ED, CMO & CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
473
+1.58%
|
-
|
|
Feb 11
2025
|
Akinbolade Oyegunwa EVP, CIO & CTO |
SELL
Payment of exercise price or tax liability
|
Direct |
42
-1.39%
|
$10,290
$245.14 P/Share
|
|
Feb 11
2025
|
Akinbolade Oyegunwa EVP, CIO & CTO |
BUY
Exercise of conversion of derivative security
|
Direct |
134
+4.25%
|
-
|
|
Feb 07
2025
|
Lance Berberian EVP, Special Advisor, Strategy |
SELL
Payment of exercise price or tax liability
|
Direct |
94
-0.57%
|
$23,124
$246.27 P/Share
|
|
Feb 07
2025
|
Lance Berberian EVP, Special Advisor, Strategy |
BUY
Exercise of conversion of derivative security
|
Direct |
354
+2.1%
|
-
|
|
Feb 07
2025
|
Glenn A Eisenberg Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
234
-0.71%
|
$57,564
$246.27 P/Share
|
|
Feb 07
2025
|
Glenn A Eisenberg Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
885
+2.62%
|
-
|
|
Feb 07
2025
|
Brian J Caveney EVP, Pres of ED, CMO & CSO |
SELL
Payment of exercise price or tax liability
|
Direct |
182
-0.31%
|
$44,772
$246.27 P/Share
|
|
Feb 07
2025
|
Brian J Caveney EVP, Pres of ED, CMO & CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
629
+1.07%
|
-
|
|
Feb 07
2025
|
Mark S Schroeder EVP, Pres Diagnostics & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
193
-1.58%
|
$47,478
$246.27 P/Share
|
|
Feb 07
2025
|
Mark S Schroeder EVP, Pres Diagnostics & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
681
+5.22%
|
-
|
|
Feb 07
2025
|
Amy B. Summy EVP, Chief Marketing Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
68
-1.45%
|
$16,728
$246.27 P/Share
|
|
Feb 07
2025
|
Amy B. Summy EVP, Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
224
+4.56%
|
-
|
|
Feb 07
2025
|
Akinbolade Oyegunwa EVP, CIO & CTO |
SELL
Payment of exercise price or tax liability
|
Direct |
51
-1.74%
|
$12,546
$246.27 P/Share
|
|
Feb 07
2025
|
Akinbolade Oyegunwa EVP, CIO & CTO |
BUY
Exercise of conversion of derivative security
|
Direct |
149
+4.83%
|
-
|
|
Feb 07
2025
|
Megan D. Bailey EVP, Pres, Central Labs & Intl |
SELL
Payment of exercise price or tax liability
|
Direct |
107
-6.98%
|
$26,322
$246.27 P/Share
|
|
Feb 07
2025
|
Megan D. Bailey EVP, Pres, Central Labs & Intl |
BUY
Exercise of conversion of derivative security
|
Direct |
291
+15.36%
|
-
|
|
Feb 07
2025
|
Vaart Sandra D Van Der EVP, Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
94
-2.81%
|
$23,124
$246.27 P/Share
|
|
Feb 07
2025
|
Vaart Sandra D Van Der EVP, Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
354
+9.58%
|
-
|
|
Feb 07
2025
|
Adam H Schechter President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,345
-1.43%
|
$330,870
$246.27 P/Share
|
|
Feb 07
2025
|
Adam H Schechter President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,250
+3.35%
|
-
|
|
Feb 07
2025
|
Peter J Wilkinson SVP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
46
-1.99%
|
$11,316
$246.27 P/Share
|
|
Feb 07
2025
|
Peter J Wilkinson SVP, Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
134
+5.49%
|
-
|
|
Feb 07
2025
|
Anita Z Graham EVP, CHRO |
SELL
Payment of exercise price or tax liability
|
Direct |
119
-13.69%
|
$29,274
$246.27 P/Share
|
|
Feb 07
2025
|
Anita Z Graham EVP, CHRO |
BUY
Exercise of conversion of derivative security
|
Direct |
369
+29.81%
|
-
|
|
Feb 06
2025
|
Lance Berberian EVP, Special Advisor, Strategy |
SELL
Payment of exercise price or tax liability
|
Direct |
94
-0.58%
|
$23,218
$247.74 P/Share
|
|
Feb 06
2025
|
Lance Berberian EVP, Special Advisor, Strategy |
BUY
Exercise of conversion of derivative security
|
Direct |
356
+2.14%
|
-
|
|
Feb 06
2025
|
Glenn A Eisenberg Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
255
-0.79%
|
$62,985
$247.74 P/Share
|
|
Feb 06
2025
|
Glenn A Eisenberg Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
966
+2.91%
|
-
|
|
Feb 06
2025
|
Brian J Caveney EVP, Pres of ED, CMO & CSO |
SELL
Payment of exercise price or tax liability
|
Direct |
212
-0.74%
|
$52,364
$247.74 P/Share
|
|
Feb 06
2025
|
Brian J Caveney EVP, Pres of ED, CMO & CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
670
+2.28%
|
-
|
|
Feb 06
2025
|
Mark S Schroeder EVP, Pres Diagnostics & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
210
-3.63%
|
$51,870
$247.74 P/Share
|